The effects of single dose nefazodone and paroxetine upon 5-HT(2A) binding potential in humans using [18F]-setoperone PET

Psychopharmacology

Volumn 144, Issue 3, 1999, Pages 279-281

  Meyer, J H ^a   Cho, R ^a   Kennedy, S ^a   Kapur, S ^a  

^a Centre for Addiction   (Canada)

Author keywords

5 HT2 receptor; Antidepressant; Depression; Positron emission tomography; Selective serotonin reuptake inhibitors; Serotonin

Indexed keywords

FLUORINE 18; NEFAZODONE; PAROXETINE; SEROTONIN 2A RECEPTOR; SETOPERONE;

ADULT; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC VALUE; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG RECEPTOR BINDING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; SEROTONIN RELEASE;

ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; BINDING, COMPETITIVE; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; MALE; PAROXETINE; PYRIMIDINONES; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, SEROTONIN; TOMOGRAPHY, EMISSION-COMPUTED; TRIAZOLES;

EID: 0032983836     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130051004     Document Type: Article

References (21)

1. 18F labeled setoperone. J Neurochem 54:1744-1754
2. Davis R, Whittington R, Bryson HM (1997) Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression. Drugs 53:608-636
3. 2 dopamine receptors in the human brain. Neurosci Lett 91: 142-147
4. 2 receptors in depression. Psychiatr Res Neuroimaging 45:227-237
5. 2 receptor in the regulation of sexual performance of male rats. Life Sci 45:1263-1270
6. Gillis MC, Welbanks L, Bergeron D, Cormier-Boyd M, Hachlorn F, Jovaisas B, Pagotto S, Repchinsky C (1998) Compendium of pharmaceuticals and specialties. Canadian Pharmacists Association, Toronto
7. 1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor. Neuropharmacology 36:461-465
8. 18F] setoperone: reproducibility of measures by the simplified reference tissue method (abstract). Neuroimage (in press)
9. 18F] setoperone in humans. Nucl Med Comm 18:395-399
10. Lane RM (1997) A critical review of selective serotonin reuptake inhibitor-related sexual dysfunction; incidence, possible aetiology and implications for management. J Psychopharmacol 11: 72-82
11. 2 receptors, roles and regulation. Ann N Y Acad Sci 600:183-191
12. 2 receptors by DOM treatment. Eur J Pharmacol 163:145-149
13. Mann JJ, Underwood MD, Arango V (1996) Postmortem studies of suicide victims. In: Watson SJ (ed) Biology of schizophrenia and affective disease." American Psychiatric Press, Washington, pp 197-221
14. 2A receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors. Psychopharmacology 133: 99-101
15. Peroutka SJ, Snyder SH (1980) Long term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210:88-90
16. Petit-Taboue M-C, Landau B, Osmont A, Tillet I, Barre L, Baron J-C (1996) Estimation of neocortical serotonin-2 binding potential by single dose fluorine-18-setoperone kinetic PET data analysis. J Nucl Med 37:95-104
17. Richelson E (1996) Synaptic effects of antidepressants. J Clin Psychopharmacol 1S-7S
18. 2-receptors in human brain. Brain Res 276:231-235
19. Seeman P (1993) Receptor tables vol 2: drug dissociation constants for neuroreceptors and transporters. Schizophr Res (Toronto)
20. Spitzer RL, Williams JBW, Gibbon M, First MB (1995) Structured clinical interview for DSM-IV patient edition. American Psychiatric Press, Washington
21. 2 agonist DOI. Neurosci Lett 141:25-29